RBC Capital Reiterates Outperform on HealthEquity, Maintains $92 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Sean Dodge has reiterated an Outperform rating for HealthEquity (NASDAQ:HQY) and maintained a price target of $92.
September 04, 2024 | 2:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated its Outperform rating for HealthEquity, maintaining a price target of $92, indicating confidence in the company's performance.
The reiteration of an Outperform rating and maintenance of a $92 price target by RBC Capital suggests a positive outlook for HealthEquity. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100